Legato Capital Management LLC Buys 10,306 Shares of U.S. Physical Therapy, Inc. $USPH

Legato Capital Management LLC raised its stake in U.S. Physical Therapy, Inc. (NYSE:USPH) by 87.3% during the fourth quarter, Holdings Channel.com reports. The institutional investor owned 22,116 shares of the company’s stock after purchasing an additional 10,306 shares during the quarter. Legato Capital Management LLC’s holdings in U.S. Physical Therapy were worth $1,727,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently made changes to their positions in USPH. Royal Bank of Canada increased its holdings in shares of U.S. Physical Therapy by 3.4% in the 1st quarter. Royal Bank of Canada now owns 79,238 shares of the company’s stock worth $5,733,000 after buying an additional 2,594 shares during the last quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. increased its holdings in shares of U.S. Physical Therapy by 4.6% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 8,897 shares of the company’s stock worth $644,000 after buying an additional 391 shares during the last quarter. Jane Street Group LLC increased its holdings in shares of U.S. Physical Therapy by 249.3% in the 1st quarter. Jane Street Group LLC now owns 49,309 shares of the company’s stock worth $3,568,000 after buying an additional 35,191 shares during the last quarter. Hsbc Holdings PLC bought a new position in shares of U.S. Physical Therapy in the 2nd quarter worth $410,000. Finally, First Trust Advisors LP increased its holdings in shares of U.S. Physical Therapy by 3.7% in the 2nd quarter. First Trust Advisors LP now owns 10,725 shares of the company’s stock worth $839,000 after buying an additional 385 shares during the last quarter.

Analyst Upgrades and Downgrades

A number of equities analysts have recently commented on USPH shares. Citizens Jmp decreased their price target on shares of U.S. Physical Therapy from $113.00 to $98.00 and set a “market outperform” rating on the stock in a report on Friday, May 8th. Citigroup reaffirmed an “outperform” rating on shares of U.S. Physical Therapy in a report on Friday, May 8th. Zacks Research lowered shares of U.S. Physical Therapy from a “hold” rating to a “strong sell” rating in a report on Tuesday, April 28th. Barrington Research reduced their target price on shares of U.S. Physical Therapy from $103.00 to $90.00 and set an “outperform” rating on the stock in a report on Wednesday, May 13th. Finally, Jefferies Financial Group raised shares of U.S. Physical Therapy to a “strong-buy” rating in a report on Thursday, March 12th. One research analyst has rated the stock with a Strong Buy rating, four have issued a Buy rating, one has issued a Hold rating and one has given a Sell rating to the stock. According to MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $97.50.

U.S. Physical Therapy Price Performance

USPH stock opened at $62.02 on Friday. The company has a debt-to-equity ratio of 0.41, a quick ratio of 1.19 and a current ratio of 1.19. U.S. Physical Therapy, Inc. has a 52 week low of $58.19 and a 52 week high of $93.50. The firm’s fifty day moving average is $71.90 and its 200 day moving average is $77.49. The firm has a market cap of $943.96 million, a P/E ratio of 124.04, a P/E/G ratio of 1.71 and a beta of 1.21.

U.S. Physical Therapy (NYSE:USPH) last released its earnings results on Wednesday, May 6th. The company reported $0.46 EPS for the quarter, missing the consensus estimate of $0.55 by ($0.09). The business had revenue of $198.29 million for the quarter, compared to the consensus estimate of $200.94 million. U.S. Physical Therapy had a net margin of 4.36% and a return on equity of 8.81%. U.S. Physical Therapy’s revenue for the quarter was up 7.9% on a year-over-year basis. During the same period in the prior year, the business posted $0.48 EPS. Research analysts predict that U.S. Physical Therapy, Inc. will post 2.99 earnings per share for the current year.

U.S. Physical Therapy Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Friday, June 12th. Shareholders of record on Friday, May 22nd will be given a dividend of $0.46 per share. The ex-dividend date of this dividend is Friday, May 22nd. This represents a $1.84 annualized dividend and a yield of 3.0%. U.S. Physical Therapy’s dividend payout ratio is presently 368.00%.

Insider Buying and Selling at U.S. Physical Therapy

In other U.S. Physical Therapy news, EVP Richard Binstein sold 3,000 shares of the stock in a transaction on Friday, March 6th. The shares were sold at an average price of $81.64, for a total transaction of $244,920.00. Following the completion of the sale, the executive vice president owned 24,867 shares of the company’s stock, valued at $2,030,141.88. This represents a 10.77% decrease in their position. The sale was disclosed in a filing with the SEC, which is available at the SEC website. Also, COO Graham D. Reeve sold 662 shares of the stock in a transaction on Wednesday, March 11th. The shares were sold at an average price of $78.86, for a total transaction of $52,205.32. Following the sale, the chief operating officer directly owned 30,078 shares of the company’s stock, valued at $2,371,951.08. The trade was a 2.15% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Corporate insiders own 2.40% of the company’s stock.

U.S. Physical Therapy Company Profile

U.S. Physical Therapy, Inc (NYSE: USPH) is a leading owner and operator of outpatient physical therapy clinics across the United States. The company delivers rehabilitative care to patients recovering from orthopedic injuries, neurological disorders and chronic conditions. Its core services include one-on-one physical therapy sessions, aquatic therapy, occupational therapy, massage therapy and sports medicine programs designed to restore mobility and enhance quality of life.

In addition to traditional rehabilitation services, U.S.